Home › Funds › AQR Capital Management › BMRN
AQR Capital Management position in BMRN
BIOMARIN PHARMACEUTICAL INC · Health Care
Latest position (Q2 2026)5.70M sh
Reported value held$322.54M
Portfolio Weight0.11%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 3.35K | $259.00K | New |
| Q4 2021 | 2.30K | $203.00K | Reduce |
| Q1 2022 | 6.11K | $471.00K | Add |
| Q2 2022 | 8.05K | $663.00K | Add |
| Q3 2022 | 29.09K | $2.47M | Add |
| Q4 2022 | 50.20K | $5.10M | Add |
| Q1 2023 | 75.70K | $7.30M | Add |
| Q2 2023 | 175.39K | $15.20M | Add |
| Q3 2023 | 89.06K | $7.88M | Reduce |
| Q4 2023 | 57.07K | $5.50M | Reduce |
| Q1 2024 | 22.66K | $1.98M | Reduce |
| Q2 2024 | 55.37K | $4.56M | Add |
| Q3 2024 | 598.50K | $42.07M | Add |
| Q4 2024 | 1.28M | $84.37M | Add |
| Q1 2025 | 2.93M | $203.99M | Add |
| Q2 2025 | 5.58M | $306.43M | Add |
| Q3 2025 | 5.93M | $321.28M | Add |
| Q4 2025 | 6.69M | $395.20M | Add |
| Q1 2026 | 7.68M | $429.35M | Add |
| Q2 2026 | 5.70M | $322.54M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding BMRN
- Vanguard Group 18.13M sh · $1.08B · Q4 2025
- Dodge & Cox 14.84M sh · $849.43M · Q2 2026
- Norges Bank Investment Management 8.21M sh · $469.66M · Q2 2026
- Viking Global Investors 7.62M sh · $435.82M · Q2 2026
- Fidelity Management & Research (FMR) 4.82M sh · $275.97M · Q2 2026
- Geode Capital Management 3.91M sh · $223.89M · Q2 2026
- Capital Research Global Investors 3.50M sh · $200.52M · Q2 2026
- Millennium Management 2.11M sh · $120.95M · Q2 2026
- Charles Schwab Investment Management 1.62M sh · $92.47M · Q2 2026
- Northern Trust Corp 1.56M sh · $89.15M · Q2 2026
- Citadel Advisors 1.40M sh · $80.28M · Q2 2026